Home / Tech News / Featured Tech News / Capcom’s Kunitsu-Gami: Path of the Goddess demo available now

Capcom’s Kunitsu-Gami: Path of the Goddess demo available now

Capcom has consistently released demos for its games ahead of time, be it for the new Monster Hunter, Resident Evil, or otherwise. Ahead of the game’s official launch on the 19th of July, Capcom have now released a demo for their upcoming new IP Kunitsu-Gami: Path of the Goddess.

Making the announcement, the team at Capcom said “Experience a taste of this unique Kagura Action Strategy game in the Kunitsu-Gami: Path of the Goddess demo, available now!”

Available across PC, PlayStation and Xbox, the demo appears to not have any limits placed upon it, time-wise, with the publisher stating “this demo allows you to play some of the stages of the main game as many times as you like without a time limit.”

Alongside the demo, Capcom also revealed that the unique genre-blending action strategy game would be getting a cool crossover with the classic and much-loved Okami series – though players will need to work to get it, saying:

“An Okami collab campaign is also now live! In the spirit of Kunitsu-Gami's villager co-operation theme, demo players around the world must co-operate to complete two missions. Succeed, and all players will receive costumes based on Amaterasu and Waka from Okami, as well as unlocking collab soundtrack for the full game!”

Kunitsu-Gami: Path of the goddess has remained mostly under the radar so far, with its unique ideas giving some potential players trepidation. It was therefore wise for Capcom to release a demo for the game ahead of time. It’ll be interesting to see what players think.

Discuss on our Facebook page HERE.

KitGuru says: Are/were you interested in Kunitsu-Gami? Will you check out the demo? Should Capcom make a proper new Okami game? Let us know down below.

Become a Patron!

Check Also

Capcom puts an end to Exoprimal development but game will remain playable

Exoprimal didn't take off in the way that Capcom had hoped, but the company still …